{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:55:56Z","timestamp":1781070956644,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.avsg.2025.09.011","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T22:09:24Z","timestamp":1758060564000},"page":"656-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Two-Year Outcomes of the French Multicentric Registry on LUMINOR Drug-Eluting Balloon for Superficial Femoral and Popliteal Arteries (LUMIFOLLOW)"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-1831","authenticated-orcid":false,"given":"Caroline","family":"Caradu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sobocinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Th\u00e9venin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Goyault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Goueffic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ducasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Destrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Biscay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Baptiste","family":"Bocquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Alain","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Coscas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Lagoarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2025.09.011_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1526602819839044","article-title":"Outcomes after drug-coated balloon treatment of femoropopliteal lesions in patients with critical limb ischemia: a post hoc analysis from the IN.PACT global study","volume":"26","author":"Reijnen","year":"2019","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2025.09.011_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-Month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2025.09.011_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2025.09.011_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2025.09.011_bib5","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2025.09.011_bib6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1526602820948240","article-title":"Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty","volume":"27","author":"Soga","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2025.09.011_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1526602819852084","article-title":"IN.PACT SFA clinical study using the IN.PACT admiral drug-coated balloon in a Chinese patient population","volume":"26","author":"Chen","year":"2019","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2025.09.011_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-Year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2025.09.011_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2025.09.011_bib10","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt I trial","volume":"9","author":"Jia","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2025.09.011_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/1526602820931477","article-title":"Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort","volume":"27","author":"Torsello","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2025.09.011_bib12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jcin.2018.02.019","article-title":"Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest pain: 2-year results from the IN.PACT global study","volume":"11","author":"Micari","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2025.09.011_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007730","article-title":"Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest pain","volume":"12","author":"Zeller","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2025.09.011_bib14","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jcin.2017.04.041","article-title":"The 24-Month results of the lutonix global SFA registry: worldwide experience with lutonix drug-coated balloon","volume":"10","author":"Thieme","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2025.09.011_bib15","first-page":"497","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-the ILLUMENATE global study: 12-month results from a prospective, multicenter, single-arm study","volume":"91","author":"Schro\u00eb","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2025.09.011_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2025.09.011_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00270-023-03478-y","article-title":"Five-Year outcomes after paclitaxel drug-coated balloon treatment of femoropopliteal lesions in diabetic and chronic limb-threatening ischemia cohorts: IN.PACT global study post hoc analysis","volume":"46","author":"Reijnen","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2025.09.011_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jvs.2024.10.068","article-title":"French multicentric registry on LUMINOR drug-eluting balloon for superficial femoral and popliteal arteries","volume":"81","author":"Caradu","year":"2024","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2025.09.011_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2025.09.011_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jvir.2019.11.015","article-title":"Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials","volume":"31","author":"Katsanos","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2025.09.011_bib21","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions","volume":"66","author":"Laird","year":"2015","journal-title":"JACC"},{"key":"10.1016\/j.avsg.2025.09.011_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcin.2015.12.267","article-title":"Drug-coated balloons for complex femoropopliteal lesions","volume":"9","author":"Schmidt","year":"2016","journal-title":"JACC Cardiovasc Interventions"},{"key":"10.1016\/j.avsg.2025.09.011_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2024.10.009","article-title":"Editor\u2019s choice \u2013 european journal of vascular and endovascular surgery publication standards for reporting vascular surgical research","volume":"69","author":"de Borst","year":"2025","journal-title":"Eur J Vasc Endovascular Surg"},{"key":"10.1016\/j.avsg.2025.09.011_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.avsg.2024.06.013","article-title":"A bibliometric analysis on adherence to reporting standards for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"109","author":"Modi","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2025.09.011_bib26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1526602815626557","article-title":"Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability","volume":"23","author":"Katsanos","year":"2016","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2025.09.011_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejvs.2023.10.011","article-title":"The 2024 ESVS guidelines on lower limb peripheral arterial disease: a step forward","volume":"67","author":"Geroulakos","year":"2024","journal-title":"Eur J Vasc Endovascular Surg"},{"key":"10.1016\/j.avsg.2025.09.011_bib28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the society for vascular surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2025.09.011_bib31","author":"Limmer"},{"key":"10.1016\/j.avsg.2025.09.011_bib33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2024.02.003","article-title":"Mortality in a nationwide practice-based cohort receiving paclitaxel-coated devices for lower limb peripheral artery disease","volume":"83","author":"Wargny","year":"2024","journal-title":"JACC"},{"key":"10.1016\/j.avsg.2025.09.011_bib34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejvs.2024.11.351","article-title":"Editor\u2019s choice \u2013 results of SurVeil versus IN.PACT admiral paclitaxel coated balloons in femoropopliteal arteries: 24 month outcomes of the randomised TRANSCEND study","volume":"69","author":"Brodmann","year":"2025","journal-title":"Eur J Vasc Endovascular Surg"},{"key":"10.1016\/j.avsg.2025.09.011_bib35","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00270-022-03265-1","article-title":"Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty: 5-year results of the randomized controlled EffPac trial","volume":"45","author":"Teichgr\u00e4ber","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2025.09.011_bib36","doi-asserted-by":"crossref","first-page":"e1322","DOI":"10.4244\/EIJ-D-23-00868","article-title":"A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions","volume":"20","author":"Scheller","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.avsg.2025.09.011_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2025.09.011_bib38","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jvs.2023.12.047","article-title":"A registry-based study of paclitaxel drug-coated balloon angioplasty for the treatment of in-stent restenosis of the femoral-popliteal artery","volume":"79","author":"Bertges","year":"2024","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2025.09.011_bib39","article-title":"Long-term clinical efficacy of drug-coated balloon angioplasty for TASCII C\/D femoropopliteal lesions in older patients with chronic limb-threatening ischemia: a retrospective study","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.avsg.2025.09.011_bib40","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCRESAHA.116.303503","article-title":"Endovascular intervention for peripheral artery disease","volume":"116","author":"Thukkani","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2025.09.011_bib41","series-title":"Drug Coated Balloon (DCB) angioplasty; DCB Norwich Registry (2009-2015) and a Propensity Score Matched Comparison between DCB and Second Generation Drug Eluting Stents","author":"Wickramarachchi","year":"2020"},{"key":"10.1016\/j.avsg.2025.09.011_bib43","first-page":"701","article-title":"Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the tack endovascular system: Tack optimized balloon angioplasty (TOBA) III 24-month results in standard and long lesions","volume":"102","author":"Brodmann","year":"2023","journal-title":"Catheterization Cardiovasc Interventions"},{"key":"10.1016\/j.avsg.2025.09.011_bib44","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","article-title":"Bioresorbable scaffold","volume":"123","author":"Onuma","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2025.09.011_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/s13019-024-03164-1","article-title":"Rotarex\u00aeS rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis","volume":"19","author":"Wang","year":"2024","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.avsg.2025.09.011_bib46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jvs.2017.06.112","article-title":"Cost-effectiveness analysis of drug-coated therapies in the superficial femoral artery","volume":"67","author":"Sridharan","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2025.09.011_bib47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.apmr.2004.06.072","article-title":"Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations","volume":"86","author":"Dillingham","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.avsg.2025.09.011_bib48","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.jcin.2022.08.004","article-title":"Low-dose vs high-dose paclitaxel-coated balloons for femoropopliteal lesions: 2-year results from the COMPARE trial","volume":"15","author":"Steiner","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2025.09.011_bib49","article-title":"Impact of calcification and infrapopliteal outflow on the outcome of endovascular treatment of femoropopliteal occlusive disease","volume":"8","author":"Athayde Soares","year":"2019","journal-title":"JRSM Cardiovasc Dis"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509625006156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509625006156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:28:55Z","timestamp":1773073735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509625006156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"alternative-id":["S0890509625006156"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2025.09.011","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-Year Outcomes of the French Multicentric Registry on LUMINOR Drug-Eluting Balloon for Superficial Femoral and Popliteal Arteries (LUMIFOLLOW)","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2025.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}